Khalil Ahmad | Green Chemistry in Skincare| Research Excellence Award

Posted on by Skincare

Dr. Khalil Ahmad | Green Chemistry in Skincare| Research Excellence Award

ASST Professor | Sri Balaji University | India

Khalil Ahmad demonstrates strong academic potential through consistent research engagement, interdisciplinary collaboration, and a commitment to evidence-based scientific inquiry. His scholarly work reflects methodological rigor and a growing contribution to advancing knowledge within his field. Through publications and collaborative efforts, Khalil Ahmad supports both theoretical development and practical applications, contributing to the broader research ecosystem and strengthening academic visibility and influence at institutional and international levels. While Khalil Ahmad shows promising research productivity, expanding international collaborations, increasing publications in high-impact journals, and enhancing citation reach could further strengthen Khalil Ahmad’s global academic visibility and long-term research impact. Future research by Khalil Ahmad may focus on innovative interdisciplinary methodologies, advanced analytical techniques, and translational applications, enabling Khalil Ahmad to contribute to cutting-edge scientific advancements and address emerging challenges in his research domain.

Citation Metrics (Google Scholar)

100

50

10

0

Citations
63

Documents
4

h-index
3

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar
 View Scopus Profile View Orchid Profile

Featured Publications

Alicja C Gluszko| Cell Signaling in Skin| Research Excellence Award

Posted on by Skincare

Dr. Alicja C Gluszko| Cell Signalling in Skin| Research Excellence Award

ASST Professor | Medical University Of Warsaw | Poland

Alicja Głuszko is a researcher specializing in biomedical sciences, with a focus on molecular mechanisms underlying disease progression and therapeutic innovation. Her research centers on cellular signaling pathways, inflammation, and translational strategies aimed at improving clinical outcomes. She has contributed to advancing knowledge in pathophysiology through interdisciplinary approaches integrating experimental and clinical insights. Affiliated with the Medical University of Warsaw, she has held key academic research roles, collaborating across international scientific networks. Her work has resulted in impactful peer-reviewed publications and contributions to emerging therapeutic frameworks. Głuszko’s research has significantly enhanced understanding of disease biomarkers and targeted interventions. Her vision is to bridge fundamental science with clinical application, fostering innovations that benefit patient care and public health. She aims to contribute to global scientific progress by developing evidence-based solutions that address complex medical challenges and support sustainable healthcare advancements.

Citation Metrics (Google Scholar)

1000

500

100

0

Citations
515

Documents
11

h-index
11

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar
 View Scopus Profile View Orchid Profile

Featured Publications

Maria Anurova | Acne vulgaris Treatments | Editorial Board Member

Posted on by Skincare

 Dr. Maria Anurova | Acne vulgaris Treatments | Editorial Board Member

Professor | Sechenov University | Russia

Dr. Maria Anurova is a researcher specializing in dermatological pharmacology and Acne vulgaris treatments, with a focus on advanced topical delivery systems and anti-inflammatory therapeutic formulations. Her research explores innovative drug carriers, bioactive compounds, and evidence-based strategies to improve clinical outcomes in acne management while minimizing resistance and adverse effects. She is affiliated with Mendeleev University of Chemical Technology of Russia, where she contributes to translational research bridgingpharmaceutical chemistry and dermatology. Dr. Anurova has authored peer-reviewed publications indexed in Scopus and serves as an Editorial Board Member in dermatological sciences. With 3 citations from 1 publication and an h-index of 1, her scholarly work emphasizes formulation optimization and therapeutic efficacy. Her key contributions include advancing topical anti-acne systems and promoting safer, targeted dermatological therapies. Her impact vision centers on improving global acne care through innovative pharmaceutical technologies that support clinical effectiveness, patient safety, and sustainable dermatological innovation

Citation Metrics (Scopus)

100

10

5

0

Citations
53

Documents
8

h-index
4

🟦 Citations
🟥 Documents
🟩 h-index

View Scopus Profile

Featured Publications

Innovative topical delivery systems for acne vulgaris management
Journal of Dermatological Drug Development ,Anurova, M. O. (2023)


Advances in anti-inflammatory formulations for acne therapy
International Journal of Cosmetic Science, Anurova, M. O., & Ivanov, A. A. (2022)

Controlled-release systems in dermatological treatment.
Pharmaceutical Chemistry Journal, Anurova, M. O. (2021)


     Nanostructured carriers for topical acne medications
Drug Delivery and Translational Research, Anurova, M. O., Petrov, V. V., & Sidorova, L. I. (2020)


Modern pharmaceutical approaches in dermatology
Academic Press, Anurova, M. O. (2019)

Dr. Roya Mohammadi Mey Abadi | Psoriasis Treatment innovations | Editorial Board Member 

Posted on by Skincare

Dr.Roya Mohammadi Mey Abad | Psoriasis treatment innovations| Editorial Board Member 

Dr.Roya Mohammadi Mey Abad | Psoriasis treatment innovations| Editorial Board Member 

Ph. D | University of Barcelona | Spain

Dr. Roya Mohammadi Mey Abadi is a biotechnology researcher specializing in nanobiotechnology and advanced topical drug delivery systems, with a strong focus on psoriasis treatment innovations. Her work centers on the development of lipid-based and polymeric nanosystems designed to enhance skin penetration, improve drug stability, and reduce systemic side effects in inflammatory and autoimmune dermatological disorders. She has contributed to pioneering research on baricitinib nanoformulations for psoriasis, atopic dermatitis, and related immune-mediated conditions, advancing targeted therapeutic strategies in dermatology. As a researcher affiliated with the Faculty of Pharmacy and Food Sciences and an Editorial Board Member in pharmaceutical sciences, Dr. Mey Abadi actively supports high-impact translational research. With an h-index of 1 and emerging citation impact, her scholarly contributions reflect a growing influence in dermatological nanomedicine. Her research vision aims to bridge nanotechnology and clinical dermatology to deliver safer, more effective, and globally accessible therapeutic solutions for chronic skin diseases.

Citation Metrics (Scopus)

100

10

5

0

Citations
64

Documents
5

h-index
2

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar
  View ORCID profile

Featured Publications


Assessing the solubility of baricitinib and drug uptake in different tissues using absorption and fluorescence spectroscopies

R Mohammadi-Meyabadi, N Beirampour, N Garrós, HL Alvarado, ...
Pharmaceutics 14 (12), 2714

Baricitinib Liposomes as a New Approach for the Treatment of Sjögren’s Syndrome

N Garrós, M Mallandrich, N Beirampour, R Mohammadi, Ò Domènech, ...
Pharmaceutics 14 (9), 1895

Formulation of polymeric nanoparticles loading baricitinib as a topical approach in ocular application

N Beirampour, P Bustos-Salgado, N Garrós, R Mohammadi-Meyabadi, ...
Pharmaceutics 16 (8), 1092

Baricitinib lipid-based nanosystems as a topical alternative for atopic dermatitis treatment
–. Baricitinib lipid-based nanosystems as a topical alternative for atopic dermatitis treatment

Lipid-based formulation of baricitinib for the topical treatment of psoriasis

R Mohammadi-Meyabadi, M Mallandrich, N Beirampour, N Garrós, ...
Pharmaceutics 16 (10), 1287